1454 related articles for article (PubMed ID: 27877033)
1. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
Lee SY; Park HY; Kim EK; Lim SY; Rhee CK; Hwang YI; Oh YM; Lee SD; Park YB
Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pulmonary function in patients with COPD, asthma-COPD overlap syndrome, and asthma with airflow limitation.
Kitaguchi Y; Yasuo M; Hanaoka M
Int J Chron Obstruct Pulmon Dis; 2016; 11():991-7. PubMed ID: 27274220
[TBL] [Abstract][Full Text] [Related]
3. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
Rennard SI; Martinez FJ; Rabe KF; Sethi S; Pizzichini E; McIvor A; Siddiqui S; Anzueto A; Zhu H
Int J Chron Obstruct Pulmon Dis; 2016; 11():1921-8. PubMed ID: 27574416
[TBL] [Abstract][Full Text] [Related]
4. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
Ding B; Small M
Int J Chron Obstruct Pulmon Dis; 2017; 12():1753-1763. PubMed ID: 28670116
[TBL] [Abstract][Full Text] [Related]
5. LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis.
Rodrigo GJ; Price D; Anzueto A; Singh D; Altman P; Bader G; Patalano F; Fogel R; Kostikas K
Int J Chron Obstruct Pulmon Dis; 2017; 12():907-922. PubMed ID: 28360514
[TBL] [Abstract][Full Text] [Related]
6. Inhaled treatment of COPD: a Delphi consensus statement.
Ninane V; Corhay JL; Germonpré P; Janssens W; Joos GF; Liistro G; Vincken W; Gurdain S; Vanvlasselaer E; Lehouck A
Int J Chron Obstruct Pulmon Dis; 2017; 12():793-801. PubMed ID: 28293106
[TBL] [Abstract][Full Text] [Related]
7. A retrospective study to assess clinical characteristics and time to initiation of open-triple therapy among patients with chronic obstructive pulmonary disease, newly established on long-acting mono- or combination therapy.
Mapel D; Laliberté F; Roberts MH; Sama SR; Sundaresan D; Pilon D; Lefebvre P; Duh MS; Patel J
Int J Chron Obstruct Pulmon Dis; 2017; 12():1825-1836. PubMed ID: 28684905
[TBL] [Abstract][Full Text] [Related]
8. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
[TBL] [Abstract][Full Text] [Related]
9. LANTERN: a randomized study of QVA149 versus salmeterol/fluticasone combination in patients with COPD.
Zhong N; Wang C; Zhou X; Zhang N; Humphries M; Wang L; Thach C; Patalano F; Banerji D;
Int J Chron Obstruct Pulmon Dis; 2015; 10():1015-26. PubMed ID: 26082625
[TBL] [Abstract][Full Text] [Related]
10. LAMA/LABA vs ICS/LABA in the treatment of COPD in Japan based on the disease phenotypes.
Hizawa N
Int J Chron Obstruct Pulmon Dis; 2015; 10():1093-102. PubMed ID: 26089659
[TBL] [Abstract][Full Text] [Related]
11. Clinical implications of blood eosinophil count in patients with non-asthma-COPD overlap syndrome COPD.
Song JH; Lee CH; Kim JW; Lee WY; Jung JY; Park JH; Jung KS; Yoo KH; Park YB; Kim DK
Int J Chron Obstruct Pulmon Dis; 2017; 12():2455-2464. PubMed ID: 28860740
[TBL] [Abstract][Full Text] [Related]
12. Association of blood eosinophils and plasma periostin with FEV1 response after 3-month inhaled corticosteroid and long-acting beta2-agonist treatment in stable COPD patients.
Park HY; Lee H; Koh WJ; Kim S; Jeong I; Koo HK; Kim TH; Kim JW; Kim WJ; Oh YM; Sin DD; Lim SY; Lee SD;
Int J Chron Obstruct Pulmon Dis; 2016; 11():23-30. PubMed ID: 26730185
[TBL] [Abstract][Full Text] [Related]
13. Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal.
Vanfleteren L; Fabbri LM; Papi A; Petruzzelli S; Celli B
Int J Chron Obstruct Pulmon Dis; 2018; 13():3971-3981. PubMed ID: 30587953
[TBL] [Abstract][Full Text] [Related]
14. The pharmacological management of asthma-chronic obstructive pulmonary disease overlap syndrome (ACOS).
Albertson TE; Chenoweth JA; Pearson SJ; Murin S
Expert Opin Pharmacother; 2020 Feb; 21(2):213-231. PubMed ID: 31955671
[No Abstract] [Full Text] [Related]
15. Comparative Effectiveness of Long-Acting Beta
Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA
Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405
[TBL] [Abstract][Full Text] [Related]
16. A Belgian survey on the diagnosis of asthma-COPD overlap syndrome.
Cataldo D; Corhay JL; Derom E; Louis R; Marchand E; Michils A; Ninane V; Peché R; Pilette C; Vincken W; Janssens W
Int J Chron Obstruct Pulmon Dis; 2017; 12():601-613. PubMed ID: 28243078
[TBL] [Abstract][Full Text] [Related]
17. Comparative safety and effectiveness of inhaled bronchodilators and corticosteroids for treating asthma-COPD overlap: a systematic review and meta-analysis.
Amegadzie JE; Gorgui J; Acheampong L; Gamble JM; Farrell J; Gao Z
J Asthma; 2021 Mar; 58(3):344-359. PubMed ID: 31668101
[TBL] [Abstract][Full Text] [Related]
18. Clinical, physiological, and radiological features of asthma-chronic obstructive pulmonary disease overlap syndrome.
Suzuki T; Tada Y; Kawata N; Matsuura Y; Ikari J; Kasahara Y; Tatsumi K
Int J Chron Obstruct Pulmon Dis; 2015; 10():947-54. PubMed ID: 26028967
[TBL] [Abstract][Full Text] [Related]
19. Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis.
Hurst JR; Dilleen M; Morris K; Hills S; Emir B; Jones R
Int J Chron Obstruct Pulmon Dis; 2018; 13():781-792. PubMed ID: 29551894
[TBL] [Abstract][Full Text] [Related]
20. The objective evaluation of obstructive pulmonary diseases with spirometry.
Ozkaya S; Dirican A; Tuna T
Int J Chron Obstruct Pulmon Dis; 2016; 11():2009-15. PubMed ID: 27616884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
